Hypoplastic  ||| S:0 E:12 ||| NNP
left  ||| S:12 E:17 ||| VBD
heart  ||| S:17 E:23 ||| NN
syndrome ||| S:23 E:31 ||| NN
:  ||| S:31 E:33 ||| :
current  ||| S:33 E:41 ||| JJ
considerations  ||| S:41 E:56 ||| NNS
and  ||| S:56 E:60 ||| CC
expectations  ||| S:60 E:73 ||| NNS
In  ||| S:73 E:76 ||| IN
the  ||| S:76 E:80 ||| DT
recent  ||| S:80 E:87 ||| JJ
era ||| S:87 E:90 ||| NN
,  ||| S:90 E:92 ||| ,
no  ||| S:92 E:95 ||| DT
congenital  ||| S:95 E:106 ||| JJ
heart  ||| S:106 E:112 ||| NN
defect  ||| S:112 E:119 ||| NN
has  ||| S:119 E:123 ||| VBZ
undergone  ||| S:123 E:133 ||| VBN
a  ||| S:133 E:135 ||| DT
more  ||| S:135 E:140 ||| RBR
dramatic  ||| S:140 E:149 ||| JJ
change  ||| S:149 E:156 ||| NN
in  ||| S:156 E:159 ||| IN
diagnostic  ||| S:159 E:170 ||| JJ
approach ||| S:170 E:178 ||| NN
,  ||| S:178 E:180 ||| ,
management ||| S:180 E:190 ||| NN
,  ||| S:190 E:192 ||| ,
and  ||| S:192 E:196 ||| CC
outcomes  ||| S:196 E:205 ||| NNS
than  ||| S:205 E:210 ||| IN
hypoplastic  ||| S:210 E:222 ||| JJ
left  ||| S:222 E:227 ||| JJ
heart  ||| S:227 E:233 ||| NN
syndrome  ||| S:233 E:242 ||| NN
( ||| S:242 E:243 ||| -LRB-
HLHS ||| S:243 E:247 ||| NNP
) ||| S:247 E:248 ||| -RRB-
.  ||| S:248 E:250 ||| .
During  ||| S:250 E:257 ||| IN
this  ||| S:257 E:262 ||| DT
time ||| S:262 E:266 ||| NN
,  ||| S:266 E:268 ||| ,
survival  ||| S:268 E:277 ||| NN
to  ||| S:277 E:280 ||| TO
the  ||| S:280 E:284 ||| DT
age  ||| S:284 E:288 ||| NN
of  ||| S:288 E:291 ||| IN
5  ||| S:291 E:293 ||| CD
years  ||| S:293 E:299 ||| NNS
( ||| S:299 E:300 ||| -LRB-
including  ||| S:300 E:310 ||| VBG
Fontan ||| S:310 E:316 ||| NNP
)  ||| S:316 E:318 ||| -RRB-
has  ||| S:318 E:322 ||| VBZ
ranged  ||| S:322 E:329 ||| VBN
from  ||| S:329 E:334 ||| IN
50 ||| S:334 E:336 ||| CD
%  ||| S:336 E:338 ||| NN
to  ||| S:338 E:341 ||| TO
69 ||| S:341 E:343 ||| CD
% ||| S:343 E:344 ||| NN
,  ||| S:344 E:346 ||| ,
but  ||| S:346 E:350 ||| CC
current  ||| S:350 E:358 ||| JJ
expectations  ||| S:358 E:371 ||| NNS
are  ||| S:371 E:375 ||| VBP
that  ||| S:375 E:380 ||| IN
70 ||| S:380 E:382 ||| CD
%  ||| S:382 E:384 ||| NN
of  ||| S:384 E:387 ||| IN
newborns  ||| S:387 E:396 ||| NNS
born  ||| S:396 E:401 ||| VBN
today  ||| S:401 E:407 ||| NN
with  ||| S:407 E:412 ||| IN
HLHS  ||| S:412 E:417 ||| NNP
may  ||| S:417 E:421 ||| MD
reach  ||| S:421 E:427 ||| VB
adulthood ||| S:427 E:436 ||| NNS
.  ||| S:436 E:438 ||| .
Although  ||| S:438 E:447 ||| IN
the  ||| S:447 E:451 ||| DT
3-stage  ||| S:451 E:459 ||| JJ
treatment  ||| S:459 E:469 ||| NN
approach  ||| S:469 E:478 ||| NN
to  ||| S:478 E:481 ||| TO
HLHS  ||| S:481 E:486 ||| NNP
is  ||| S:486 E:489 ||| VBZ
now  ||| S:489 E:493 ||| RB
well  ||| S:493 E:498 ||| RB
founded ||| S:498 E:505 ||| VBN
,  ||| S:505 E:507 ||| ,
there  ||| S:507 E:513 ||| EX
is  ||| S:513 E:516 ||| VBZ
significant  ||| S:516 E:528 ||| JJ
variation  ||| S:528 E:538 ||| NN
among  ||| S:538 E:544 ||| IN
centers ||| S:544 E:551 ||| NNS
.  ||| S:551 E:553 ||| .
In  ||| S:553 E:556 ||| IN
this  ||| S:556 E:561 ||| DT
white  ||| S:561 E:567 ||| JJ
paper ||| S:567 E:572 ||| NN
,  ||| S:572 E:574 ||| ,
we  ||| S:574 E:577 ||| PRP
present  ||| S:577 E:585 ||| VBP
the  ||| S:585 E:589 ||| DT
current  ||| S:589 E:597 ||| JJ
state  ||| S:597 E:603 ||| NN
of  ||| S:603 E:606 ||| IN
the  ||| S:606 E:610 ||| DT
art  ||| S:610 E:614 ||| NN
in  ||| S:614 E:617 ||| IN
our  ||| S:617 E:621 ||| PRP$
understanding  ||| S:621 E:635 ||| NN
and  ||| S:635 E:639 ||| CC
treatment  ||| S:639 E:649 ||| NN
of  ||| S:649 E:652 ||| IN
HLHS  ||| S:652 E:657 ||| NNP
during  ||| S:657 E:664 ||| IN
the  ||| S:664 E:668 ||| DT
stages  ||| S:668 E:675 ||| NNS
of  ||| S:675 E:678 ||| IN
care ||| S:678 E:682 ||| NN
:  ||| S:682 E:684 ||| :
1 ||| S:684 E:685 ||| LS
)  ||| S:685 E:687 ||| -RRB-
pre-Stage  ||| S:687 E:697 ||| JJ
I ||| S:697 E:698 ||| NN
:  ||| S:698 E:700 ||| :
fetal  ||| S:700 E:706 ||| JJ
and  ||| S:706 E:710 ||| CC
neonatal  ||| S:710 E:719 ||| JJ
assessment  ||| S:719 E:730 ||| NN
and  ||| S:730 E:734 ||| CC
management ||| S:734 E:744 ||| NN
;  ||| S:744 E:746 ||| :
2 ||| S:746 E:747 ||| LS
)  ||| S:747 E:749 ||| -RRB-
Stage  ||| S:749 E:755 ||| NN
I ||| S:755 E:756 ||| PRP
:  ||| S:756 E:758 ||| :
perioperative  ||| S:758 E:772 ||| JJ
care ||| S:772 E:776 ||| NN
,  ||| S:776 E:778 ||| ,
interstage  ||| S:778 E:789 ||| JJ
monitoring ||| S:789 E:799 ||| NN
,  ||| S:799 E:801 ||| ,
and  ||| S:801 E:805 ||| CC
management  ||| S:805 E:816 ||| NN
strategies ||| S:816 E:826 ||| NNS
;  ||| S:826 E:828 ||| :
3 ||| S:828 E:829 ||| LS
)  ||| S:829 E:831 ||| -RRB-
Stage  ||| S:831 E:837 ||| NNP
II ||| S:837 E:839 ||| NNP
:  ||| S:839 E:841 ||| :
surgeries ||| S:841 E:850 ||| CD
;  ||| S:850 E:852 ||| :
4 ||| S:852 E:853 ||| LS
)  ||| S:853 E:855 ||| -RRB-
Stage  ||| S:855 E:861 ||| NNP
III ||| S:861 E:864 ||| NNP
:  ||| S:864 E:866 ||| :
Fontan  ||| S:866 E:873 ||| NNP
surgery ||| S:873 E:880 ||| NN
;  ||| S:880 E:882 ||| :
and  ||| S:882 E:886 ||| CC
5 ||| S:886 E:887 ||| CD
)  ||| S:887 E:889 ||| -RRB-
long-term  ||| S:889 E:899 ||| JJ
follow-up ||| S:899 E:908 ||| NN
.  ||| S:908 E:910 ||| .
Issues  ||| S:910 E:917 ||| NNS
surrounding  ||| S:917 E:929 ||| VBG
the  ||| S:929 E:933 ||| DT
genetics  ||| S:933 E:942 ||| NN
of  ||| S:942 E:945 ||| IN
HLHS ||| S:945 E:949 ||| NNP
,  ||| S:949 E:951 ||| ,
developmental  ||| S:951 E:965 ||| JJ
outcomes ||| S:965 E:973 ||| NNS
,  ||| S:973 E:975 ||| ,
and  ||| S:975 E:979 ||| CC
quality  ||| S:979 E:987 ||| NN
of  ||| S:987 E:990 ||| IN
life  ||| S:990 E:995 ||| NN
are  ||| S:995 E:999 ||| VBP
addressed  ||| S:999 E:1009 ||| VBN
in  ||| S:1009 E:1012 ||| IN
addition  ||| S:1012 E:1021 ||| NN
to  ||| S:1021 E:1024 ||| TO
the  ||| S:1024 E:1028 ||| DT
many  ||| S:1028 E:1033 ||| JJ
other  ||| S:1033 E:1039 ||| JJ
considerations  ||| S:1039 E:1054 ||| NNS
for  ||| S:1054 E:1058 ||| IN
caring  ||| S:1058 E:1065 ||| VBG
for  ||| S:1065 E:1069 ||| IN
this  ||| S:1069 E:1074 ||| DT
group  ||| S:1074 E:1080 ||| NN
of  ||| S:1080 E:1083 ||| IN
complex  ||| S:1083 E:1091 ||| JJ
patients ||| S:1091 E:1099 ||| NNS
.  ||| S:1099 E:1101 ||| .
